NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America
June 11, 2024 08:40 ET
|
NEXGEL, INC.
LANGHORNE, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle,...